ITGA2B and aneurysm: In rats models the anti-integrin GPIIb/IIIa antibody Abciximab (Reopro) limited ILT formation and prevented aneurysm dilatation [46] and the P2Y12 receptor antagonist Ticagrelor proved protective, as rats developed smaller aneurysms [47].